chr18-31080357-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024422.6(DSC2):c.1264-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000484 in 1,613,350 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_024422.6 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.1264-5C>T | splice_region_variant, intron_variant | ENST00000280904.11 | NP_077740.1 | |||
DSC2 | NM_004949.5 | c.1264-5C>T | splice_region_variant, intron_variant | NP_004940.1 | ||||
DSC2 | NM_001406506.1 | c.835-5C>T | splice_region_variant, intron_variant | NP_001393435.1 | ||||
DSC2 | NM_001406507.1 | c.835-5C>T | splice_region_variant, intron_variant | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.1264-5C>T | splice_region_variant, intron_variant | 1 | NM_024422.6 | ENSP00000280904.6 | ||||
DSC2 | ENST00000251081.8 | c.1264-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000251081.6 | |||||
DSC2 | ENST00000648081.1 | c.835-5C>T | splice_region_variant, intron_variant | ENSP00000497441.1 | ||||||
DSC2 | ENST00000682357.1 | c.835-5C>T | splice_region_variant, intron_variant | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.00262 AC: 399AN: 152160Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.000688 AC: 172AN: 250080Hom.: 1 AF XY: 0.000592 AC XY: 80AN XY: 135162
GnomAD4 exome AF: 0.000262 AC: 383AN: 1461072Hom.: 2 Cov.: 33 AF XY: 0.000230 AC XY: 167AN XY: 726764
GnomAD4 genome AF: 0.00261 AC: 398AN: 152278Hom.: 4 Cov.: 33 AF XY: 0.00258 AC XY: 192AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 19, 2012 | c.1264-5C>T in Intron 09 of DSC2: This variant is not expected to have clinical significance because it has been identified in 1.0% (38/3738) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS;). - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Arrhythmogenic right ventricular dysplasia 11 Benign:2
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Jun 28, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiomyopathy Benign:2
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Aug 22, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 16, 2018 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 08, 2022 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 25, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Familial isolated arrhythmogenic right ventricular dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Sep 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at